Works by Yahng, S-A

Results: 8

Mutation in TET2 or TP53 predicts poor survival in patients with myelodysplastic syndrome receiving hypomethylating treatment or stem cell transplantation.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 8, p. 1132, doi. 10.1038/bmt.2015.110

By:

Kim, M;
Yahng, S-A;
Kwon, A;
Park, J;
Jeon, Y-W;
Yoon, J-H;
Shin, S-H;
Lee, S-E;
Cho, B-S;
Eom, K-S;
Lee, S;
Min, C-K;
Kim, H-J;
Cho, S-G;
Kim, D-W;
Lee, J-W;
Min, W-S;
Lee, S-H;
Kim, Y-J

Publication type:

Article

Impact of IKZF1 deletions on long-term outcomes of allo-SCT following imatinib-based chemotherapy in adult Philadelphia chromosome-positive ALL.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 3, p. 354, doi. 10.1038/bmt.2014.281

By:

Kim, M;
Park, J;
Kim, D-W;
Kim, Y-J;
Jeon, Y-W;
Yoon, J-H;
Shin, S-H;
Yahng, S-A;
Lee, S-E;
Cho, B-S;
Eom, K-S;
Kim, H-J;
Min, C-Ki;
Cho, S-G;
Kim, Y;
Lee, J-W;
Han, K;
Min, W-S;
Lee, S

Publication type:

Article

PBSC vs BM grafts with myeloablative conditioning for unrelated donor transplantation in adults with high-risk ALL.

Published in:

Bone Marrow Transplantation, 2014, v. 49, n. 6, p. 773, doi. 10.1038/bmt.2014.54

By:

Shin, S-H;
Yoon, J-H;
Yahng, S-A;
Lee, S-E;
Cho, B-S;
Eom, K-S;
Kim, Y-J;
Kim, H-J;
Min, C-K;
Cho, S-G;
Kim, D-W;
Lee, J-W;
Min, W-S;
Park, C-W;
Lee, S

Publication type:

Article

Experiences of t-PA use in moderate-to-severe hepatic veno-occlusive disease after hematopoietic SCT: is it still reasonable to use t-PA?

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 12, p. 1562, doi. 10.1038/bmt.2013.101

By:

Yoon, J-H;
Min, W-S;
Kim, H-Je;
Kim, J-H;
Shin, S-H;
Yahng, S-A;
Lee, S-E;
Cho, B-S;
Eom, K-S;
Kim, Y-J;
Lee, S;
Min, C-K;
Cho, S-G;
Kim, D-W;
Lee, J-W;
Park, C-W

Publication type:

Article

Survival benefits with transplantation in secondary AML evolving from myelodysplastic syndrome with hypomethylating treatment failure.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 5, p. 678, doi. 10.1038/bmt.2012.214

By:

Shin, S-H;
Yahng, S-A;
Yoon, J-H;
Lee, S-E;
Cho, B-S;
Eom, K-S;
Lee, S;
Min, C-K;
Kim, H-J;
Cho, S-G;
Kim, D-W;
Lee, J-W;
Min, W-S;
Park, C-W;
Kim, Y-J

Publication type:

Article

Risk and prognostic factors for acute GVHD based on NIH consensus criteria.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 4, p. 587, doi. 10.1038/bmt.2012.187

By:

Lee, S-E;
Cho, B-S;
Kim, J-H;
Yoon, J-H;
Shin, S-H;
Yahng, S-A;
Eom, K-S;
Kim, Y-J;
Kim, H-J;
Lee, S;
Min, C-K;
Cho, S-G;
Kim, D-W;
Lee, J-W;
Min, W-S;
Park, C-W

Publication type:

Article

Impact of minimal residual disease kinetics during imatinib-based treatment on transplantation outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia.

Published in:

Leukemia (08876924), 2012, v. 26, n. 11, p. 2367, doi. 10.1038/leu.2012.164

By:

Lee, S;
Kim, D-W;
Cho, B-S;
Yoon, J-H;
Shin, S-H;
Yahng, S-A;
Lee, S-E;
Eom, K-S;
Kim, Y-J;
Chung, N-G;
Kim, H-J;
Min, C-K;
Lee, J-W;
Min, W-S;
Park, C-W

Publication type:

Article

The first case of acute lymphoblastic leukemia with the e19a2 BCR-ABL1 transcript: imatinib therapy followed by unrelated donor transplantation induces a durable molecular response.

Published in:

2011

By:

Jeon, E. K.;
Lim, J.;
Kim, M.;
Yahng, S.-A.;
Lee, S.-E.;
Cho, B.-S.;
Kim, Y.-J.;
Kim, H.-J.;
Min, C.-K.;
Cho, S.-G.;
Kim, D.-W.;
Lee, J.-W.;
Min, W.-S.;
Park, C.-W.;
Lee, S.

Publication type:

Letter